Dr Nick Camp is a medicinal chemist with 22 years drug discovery experience gained within major pharma and biotech. As a group leader at Eli Lilly he drove the diversification of the UK chemistry group resulting in a significant increase in portfolio deliverables for the department, including multiple clinical candidates. During his time in biotech, Nick was involved in a successful collaboration that delivered the Factor Xa clinical compound LY517717 involving one of the earliest fragment based design approaches. He has extensive project leadership experience having worked across all phases of pre-clinical drug discovery and is recognised for developing future leaders. Nick helped to enhance links between Academia and Pharma through his role as Entrepreneur in Residence at the University of Southampton. He has a good track record of publications including, 14 scientific publications and 11 patents.
Expertise: Small Molecule Drug Discovery, Medicinal Chemistry Strategies, Project Leadership, Enzyme inhibitors, SBDD, FBDD, Issue-driven and Multi-dimensional SARs, Virtual Libraries, Artificial Intelligence, Lead Optimisation, Hit to Lead, Early Portfolio, Target Validation, Staff Development and Mentorship.